Ophthalmic Drugs Market is Estimated to Witness High Growth Owing to Opportunity to Treat Various Eye Diseases
Ophthalmic Drugs Market |
Ophthalmic drugs are medical drugs used for the treatment of various eye diseases and disorders. Some key ophthalmic drugs include anti-glaucoma drugs, dry eye medication, anti-infective drugs, anti-allergic drugs, non-steroidal anti-inflammatory drugs, and others. These drugs are used for treating various eye conditions like glaucoma, conjunctivitis, uveitis, dry eyes, infection, allergy, inflammation and other retinal diseases. The need for ophthalmic drugs is growing owing to the rising prevalence of eye diseases globally.
The Global
Ophthalmic Drugs Market is estimated to be valued at US$ 48.19 Bn in 2023 and
is expected to exhibit a CAGR of 8.9% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The growing geriatric population remains one of the major opportunities for the
ophthalmic drugs market. Age is one of the major risk factors for various
ocular diseases like age-related macular degeneration, glaucoma, diabetic
retinopathy and others. As per estimates, the global geriatric population aged
65 years or older is expected to double from 703 million in 2019 to more than
1.5 billion by 2050. The aging population is more prone to develop ocular
disorders owing to physiological changes in the eyes associated with aging.
With the rising elderly population globally, the demand and sales of ophthalmic
drugs are expected to grow significantly during the forecast period. The market
players can capitalize on this opportunity by developing effective and safe
drugs for age-related ocular diseases which have a huge patient pool worldwide.
Porter's Analysis
Threat of new entrants: Low due to high capital requirements for R&D and
clinical trials.
Bargaining power of buyers: High as buyers have many
substitutes from different manufacturers to choose from.
Bargaining power of suppliers: Moderate as suppliers
have specialized ingredients and manufacturing capabilities.
Threat of new substitutes: Moderate as new drugs can
disrupt existing market but take time for approval and adoption.
Competitive rivalry: Intense as major players compete
on basis of pricing, innovation and branding.
SWOT Analysis
Strengths: Large patient pool, increasing healthcare spending, new product
launches. Weaknesses: Stringent regulations, patent expirations, pricing
pressures.
Opportunities: Untapped emerging markets, growth in
chronic diseases, collaboration with local players. Threats: Reimbursement
issues, political and economic uncertainties.
Key Takeaways
Global
Ophthalmic Drugs Market Demand is expected to witness high growth over
the forecast period of 2023 to 2030. The Global Ophthalmic Drugs Market is
estimated to be valued at US$ 48.19 Bn in 2023 and is expected to exhibit a
CAGR of 8.9% over the forecast period 2023 to 2030.
Comments
Post a Comment